Rights and permissions
About this article
Cite this article
Efavirenz-based vs triple-nucleoside regimens for HIV. Inpharma Wkly. 1588, 14 (2007). https://doi.org/10.2165/00128413-200715880-00039
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715880-00039